Ki Ho Hong

TL;DR: Kim et al. as mentioned in this paper proposed guidelines for diagnosing COVID-19 in clinical laboratories in Korea based on other related domestic and international guidelines, as well as expert opinions and include the selection of test subjects, selection of specimens, diagnostic methods, interpretation of test results, and biosafety.

TL;DR: Clinical characteristics, cytokine/chemokine concentrations, viral shedding and antibody kinetics in 30 patients with Middle East respiratory syndrome (MERS), including 6 non-survivors admitted to 3 MERS-designated hospitals, found old age, low albumin, altered mentality and high pneumonia severity index score at admission were risk factors for mortality.

TL;DR: Reinfection with a genetically distinct SARS-CoV-2 strain may occur in an immunocompetent patient shortly after recovery from mild COVID-19.

TL;DR: The ability of three phenotypic systems to identify R. ornithinolytica compared with the genotypic methods sequence-specific primer PCR (SSP-PCR), 16S rRNA gene sequence analysis using the MicroSeq 500 system16S rDNA bacterial identification system or comparison with GenBank sequences using blast is evaluated.

TL;DR: Low plasma anticoagulant levels reflect florid consumption of the phys iologic defense system against DIC-induced hypercoagulation, suggesting that these factors are good indicators of DIC severity.